compounded semaglutide shortage US judge upholds FDA's removal of Ozempic, Wegovy from drug list Ozempic copies restricted after US

Monlunabant: Effective but with Side Effects Monlunabant, a weight loss drug used for chronic weight management and metabolic disorders, has shown promising results in clinical trials but comes with notable side effects

A small error in reconstitution volume cascades into a significant dosing error over weeks of treatment

A licensed provider makes the final determination based on your full medical history, current medications, and any contraindications

Evaluating causal protective effect of dual GLP-1R/GIPR agonists on MASLD: a Mendelian randomization and colocalization study

Request and review the Certificate of Analysis (COA) to confirm the use of semaglutide base API

excessively low LDL could have unknown consequences